Measuring and Modeling Health Care Costs
9780226530857
9780226530994
Measuring and Modeling Health Care Costs
Health care costs represent a nearly 18% of U.S. gross domestic product and 20% of government spending. While there is detailed information on where these health care dollars are spent, there is much less evidence on how this spending affects health.
The research in Measuring and Modeling Health Care Costs seeks to connect our knowledge of expenditures with what we are able to measure of results, probing questions of methodology, changes in the pharmaceutical industry, and the shifting landscape of physician practice. The research in this volume investigates, for example, obesity’s effect on health care spending, the effect of generic pharmaceutical releases on the market, and the disparity between disease-based and population-based spending measures. This vast and varied volume applies a range of economic tools to the analysis of health care and health outcomes.
Practical and descriptive, this new volume in the Studies in Income and Wealth series is full of insights relevant to health policy students and specialists alike.
The research in Measuring and Modeling Health Care Costs seeks to connect our knowledge of expenditures with what we are able to measure of results, probing questions of methodology, changes in the pharmaceutical industry, and the shifting landscape of physician practice. The research in this volume investigates, for example, obesity’s effect on health care spending, the effect of generic pharmaceutical releases on the market, and the disparity between disease-based and population-based spending measures. This vast and varied volume applies a range of economic tools to the analysis of health care and health outcomes.
Practical and descriptive, this new volume in the Studies in Income and Wealth series is full of insights relevant to health policy students and specialists alike.
512 pages | 62 line drawings, 113 tables | 6 x 9 | © 2018
National Bureau of Economic Research Studies in Income and Wealth
Economics and Business: Health Economics
Table of Contents
Prefatory Note
Introduction
Ana Aizcorbe, Colin Baker, Ernst R. Berndt, and David M. Cutler
I. Methodological Issues in Measuring Health Care Costs and Outcomes
1. Measuring Health Services in the National Accounts: An International Perspective
Paul Schreyer and Matilde Mas
Comment: J. Steven Landefeld
2. A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis
Armando Franco, Dana Goldman, Adam Leive, and Daniel McFadden
3. Decomposing Medical Care Expenditure Growth
Abe Dunn, Eli Liebman, and Adam Hale Shapiro
4. Calculating Disease-Based Medical Care Expenditure Indexes for Medicare Beneficiaries: A Comparison of Method and Data Choices
Anne E. Hall and Tina Highfill
II. Analyses of Subpopulations and Market Segments
5. Measuring Output and Productivity in Private Hospitals
Brian Chansky, Corby Garner, and Ronjoy Raichoudhary
6. Attribution of Health Care Costs to Diseases: Does the Method Matter?
Allison B. Rosen, Ana Aizcorbe, Tina Highfill, Michael E. Chernew, Eli Liebman, Kaushik Ghosh, and David M. Cutler
7. The Simultaneous Effects of Obesity, Insurance Choice, and Medical Visit Choice on Health Care Costs
Ralph Bradley and Colin Baker
III. Prescription Pharmaceutical Markets
8. The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity
Murray L. Aitken, Ernst R. Berndt, Barry Bosworth, Iain M. Cockburn, Richard Frank, Michael Kleinrock, and Bradley T. Shapiro
9. Specialty Drug Prices and Utilization after Loss of US Patent Exclusivity, 2001–2007
Rena M. Conti and Ernst R. Berndt
10. Drug Shortages, Pricing, and Regulatory Activity
Christopher Stomberg
IV. Issues in Industrial Organization and Market Design
11. Measuring Physician Practice Competition Using Medicare Data
Laurence C. Baker, M. Kate Bundorf, and Anne Royalty
12. Risk Adjustment of Health Plan Payments to Correct Inefficient Plan Choice from Adverse Selection
Jacob Glazer, Thomas G. McGuire, and Julie Shi
13. Going into the Affordable Care Act: Measuring the Size, Structure, and Performance of the Individual and Small Group Markets for Health Insurance
Pinar Karaca-Mandic, Jean M. Abraham, Kosali Simon, and Roger Feldman
V. Potpourri
14. The Distribution of Public Spending for Health Care in the United States on the Eve of Health Reform
Didem Bernard, Thomas Selden, and Yuriy Pylypchuk
15. The Impact of Biomedical Research on US Cancer Mortality: A Bibliometric Analysis
Frank R. Lichtenberg
Contributors
Author Index
Subject Index
Introduction
Ana Aizcorbe, Colin Baker, Ernst R. Berndt, and David M. Cutler
I. Methodological Issues in Measuring Health Care Costs and Outcomes
1. Measuring Health Services in the National Accounts: An International Perspective
Paul Schreyer and Matilde Mas
Comment: J. Steven Landefeld
2. A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis
Armando Franco, Dana Goldman, Adam Leive, and Daniel McFadden
3. Decomposing Medical Care Expenditure Growth
Abe Dunn, Eli Liebman, and Adam Hale Shapiro
4. Calculating Disease-Based Medical Care Expenditure Indexes for Medicare Beneficiaries: A Comparison of Method and Data Choices
Anne E. Hall and Tina Highfill
II. Analyses of Subpopulations and Market Segments
5. Measuring Output and Productivity in Private Hospitals
Brian Chansky, Corby Garner, and Ronjoy Raichoudhary
6. Attribution of Health Care Costs to Diseases: Does the Method Matter?
Allison B. Rosen, Ana Aizcorbe, Tina Highfill, Michael E. Chernew, Eli Liebman, Kaushik Ghosh, and David M. Cutler
7. The Simultaneous Effects of Obesity, Insurance Choice, and Medical Visit Choice on Health Care Costs
Ralph Bradley and Colin Baker
III. Prescription Pharmaceutical Markets
8. The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity
Murray L. Aitken, Ernst R. Berndt, Barry Bosworth, Iain M. Cockburn, Richard Frank, Michael Kleinrock, and Bradley T. Shapiro
9. Specialty Drug Prices and Utilization after Loss of US Patent Exclusivity, 2001–2007
Rena M. Conti and Ernst R. Berndt
10. Drug Shortages, Pricing, and Regulatory Activity
Christopher Stomberg
IV. Issues in Industrial Organization and Market Design
11. Measuring Physician Practice Competition Using Medicare Data
Laurence C. Baker, M. Kate Bundorf, and Anne Royalty
12. Risk Adjustment of Health Plan Payments to Correct Inefficient Plan Choice from Adverse Selection
Jacob Glazer, Thomas G. McGuire, and Julie Shi
13. Going into the Affordable Care Act: Measuring the Size, Structure, and Performance of the Individual and Small Group Markets for Health Insurance
Pinar Karaca-Mandic, Jean M. Abraham, Kosali Simon, and Roger Feldman
V. Potpourri
14. The Distribution of Public Spending for Health Care in the United States on the Eve of Health Reform
Didem Bernard, Thomas Selden, and Yuriy Pylypchuk
15. The Impact of Biomedical Research on US Cancer Mortality: A Bibliometric Analysis
Frank R. Lichtenberg
Contributors
Author Index
Subject Index